Evidence map›Paper›PMID 33953283›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2021

Correction to: LncRNA GAS5 activates the HIF1A/VEGF pathway by binding to TAF15 to promote wound healing in diabetic foot ulcers.

Wei-Xia Peng, Pei-Xiang He, Li-Jun Liu, Ting Zhu, Ya-Qin Zhong, Lin Xiang, Ke Peng, Jing-Jin Yang, Guang-Da Xiang

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wei-Xia PengThe First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, PR China.
Pei-Xiang HeDepartment of Endocrine, Yiyang Central Hospital, Yiyang, Hunan, PR China.
Li-Jun LiuDepartment of Endocrine, Yiyang Central Hospital, Yiyang, Hunan, PR China.
Ting ZhuDepartment of Endocrine, Yiyang Central Hospital, Yiyang, Hunan, PR China.
Ya-Qin ZhongDepartment of Endocrine, Yiyang Central Hospital, Yiyang, Hunan, PR China.
Lin XiangDepartment of Endocrine, Central Theater General Hospital of PLA, Wuhan, Hubei, PR China.
Ke PengDepartment of Endocrine, Yiyang Central Hospital, Yiyang, Hunan, PR China.
Jing-Jin YangDepartment of Endocrine, Huaihua First People's Hospital, Huaihua, Hunan, PR China.
Guang-Da XiangThe First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, PR China. xianggdd015@163.com.
Central Hospital of Wuhan · CNHuaian First People’s Hospital · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33953283
OpenAlexW3158431929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.